An autopsy is a specialized surgical procedure consisting of external and internal examination of a deceased individual for the purposes of documenting abnormalities and determining or confirming medical diagnoses that may have contributed to their death. One of the benefits of an autopsy is the opportunity to collect and store biospecimens for the purposes of biobanking. This chapter outlines the procedures necessary to procure, store, and utilize biospecimens obtained during an autopsy. With the emergence of molecular diagnostics, this chapter also discusses factors that influence the integrity of autopsy biospecimens prior to procurement. These include the postmortem interval, as well as premortem factors such as the patient’s agonal state, biospecimen temperature, and pH.
Autopsy Biobank Biospecimen Integrity Postmortem interval Agonal state Temperature pH
This is a preview of subscription content, log in to check access.
Springer Nature is developing a new tool to find and evaluate Protocols. Learn more
This work was supported in part by NIH:NCI P50-CA211015, NIH:NIMH U24 MH100929, the Art of the Brain Foundation, and the Henry E. Singleton Brain Cancer Research Program.
Yong WH, Dry SM, Shabihkhani M (2014) A practical approach to clinical and research biobanking. Methods Mol Biol 1180:137–162CrossRefGoogle Scholar
Espina V, Mueller C, Edmiston K et al (2009) Tissue is alive: new technologies are needed to address the problems of protein biomarker pre-analytical variability. Proteomics Clin Appl 3(8):874–882CrossRefGoogle Scholar
Barton AJ, Pearson RC, Najlerahim A, Harrison PJ (1993) Pre- and postmortem influences on brain RNA. J Neurochem 61(1):1–11CrossRefGoogle Scholar
Phang TW, Shi CY, Chia JN, Ong CN (1994) Amplification of cDNA via RT-PCR using RNA extracted from postmortem tissues. J Forensic Sci 39(5):1275–1279CrossRefGoogle Scholar
Vennemann M, Koppelkamm A (2010) Postmortem mRNA profiling II: practical considerations. Forensic Sci Int 203(1–3):76–82CrossRefGoogle Scholar
Preece P, Cairns NJ (2003) Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance. Brain Res Mol Brain Res 118(1–2):60–71CrossRefGoogle Scholar
Kingsbury AE, Foster OJ, Nisbet AP et al (1995) Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res 28(2):311–318CrossRefGoogle Scholar
Li JZ, Vawter MP, Walsh DM et al (2004) Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet 13(6):609–616CrossRefGoogle Scholar
Tomita H, Vawter MP, Walsh DM et al (2004) Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry 55(4):346–352CrossRefGoogle Scholar
Stan AD, Ghose S, Gao XM et al (2006) Human postmortem tissue: what quality markers matter? Brain Res 1123(1):1–11CrossRefGoogle Scholar
Mall G, Eisenmenger W (2005) Estimation of time since death by heat-flow Finite-Element model. Part I: Method, model, calibration and validation. Leg Med (Tokyo) 7(1):1–14CrossRefGoogle Scholar
Schroeder A, Mueller O, Stocker S et al (2006) The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 7(3):1–14Google Scholar
Ma MJ, Perry A, Brat DJ (eds) (2010) Biopsy pathology of neurodegenerative disorders in adults. Practical surgical neuropathology: a diagnostic approach. Churchill Livingstone/Elsevier, Philadelphia, pp 566–570Google Scholar
Ellison D, Love S et al (2013) Prion diseases. In: Neuropathology: a reference text of CNS pathology, 3rd edn. Mosby/Elsevier, USA, p 676Google Scholar
Liu A, Pollard K (2015) Biobanking for personalized medicine. In: Biobanking in the 21st century. Springer International Publishing, Switzerland, pp 55–68CrossRefGoogle Scholar
Molina DK (2010) Collection and selection of toxicologic specimens. In: Handbook of forensic toxicology for medical examiners. CRC Press/Taylor & Francis Group, New York, pp 1–6Google Scholar
Teunissen CE, Tumani H, Bennett JL et al (2011) Consensus guidelines for CSF and blood biobanking for CNS biomarker studies. Mult Scler Int 2011:246412PubMedPubMedCentralGoogle Scholar